254News

News Beyond News

Ulcer Drug Recalled from Kenyan Market over cancer risk

1 min read
Spread the post

The Pharmacy and Poisons Board has issued a directive to recall all Ranitidine products from the Kenyan market.

Ranitidine is a drug used in management of ulcers. Recently, concerns were raised about the drug which was said to be contaminated with the chemical N-nitrosodimethylamine (NDMA), a potential cancer causing agent in humans.

In a letter by the board’s CEO Dr Siyoi addressed to company pharmacists, the board instructed the importers to carry out a level 2 recall as well as furnish the board with details of all Ranitidine products they had imported into the country.

Here is the statement;


Spread the post

Do you have a groundbreaking story you would like us to publish? Please reach us through info@254news.co.ke. Contact 254news.co.ke Instantly.